Handa Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HANDA THERAP
HANDA THERAP has one approved drug.
There are six US patents protecting HANDA THERAP drugs.
Summary for Handa Therap
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Handa Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Handa Therap | PHYRAGO | dasatinib | TABLET;ORAL | 216099-005 | Dec 5, 2023 | RX | Yes | Yes | 11,298,356 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Handa Therap | PHYRAGO | dasatinib | TABLET;ORAL | 216099-005 | Dec 5, 2023 | RX | Yes | Yes | 12,544,376 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Handa Therap | PHYRAGO | dasatinib | TABLET;ORAL | 216099-001 | Dec 5, 2023 | RX | Yes | No | 11,324,745 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Handa Therap | PHYRAGO | dasatinib | TABLET;ORAL | 216099-006 | Dec 5, 2023 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Handa Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 3168667 | ⤷ Start Trial |
| Japan | 7738961 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2021150981 | ⤷ Start Trial |
| European Patent Office | 4714503 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Handa Therap Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1169038 | C300567 | Netherlands | ⤷ Start Trial | PRODUCT NAME: DASATINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/06/363/001 .... 009 20061120 |
| 1169038 | 122013000012 | Germany | ⤷ Start Trial | PRODUCT NAME: DASATINIB UND PHARMAZEUTISCH GEEIGNETE SALZE DAVON; REGISTRATION NO/DATE: EU/1/06/363/001-009 EU/1/06/363/010-011 EU/1/06/363/012-015 20061120 |
| 1169038 | 132013902119320 | Italy | ⤷ Start Trial | PRODUCT NAME: DASATINIB E I SUOI SALI FARMACEUTICAMENTE ACCETTABILI(SPRYCEL); AUTHORISATION NUMBER(S) AND DATE(S): DA EU/1/06/363/001 A EU/I/06/363/015, 20061120 |
| 1169038 | 300567 | Netherlands | ⤷ Start Trial | PRODUCT NAME: DASATINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/06/363/001 - 009 20061120 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
